Prospect News: News for AMAG Pharmaceuticals, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with A > Issuers starting with A, CV only > All stories on AMAG Pharmaceuticals, Inc. > Stories on AMAG Pharmaceuticals, Inc., CV only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

AMAG Pharmaceuticals, Inc.

11/17/2020	CVLM	AMAG 3Ľ% convertibles due 2022 are putable, amended as merger closes
10/5/2020	CV	Market Commentary: Livent convertible notes in focus, expand in secondary; Cinemark tanks; AMAG trades down
10/1/2020	CV	Market Commentary: AMAG convertibles skyrocket on buyout; j2 Global active; SolarEdge gains outright
10/1/2020	CVLM	AMAG 3Ľ% convertible holders to have put right following merger
10/1/2020	CV	Market Commentary: Morning Commentary: AMAG convertibles skyrocket on buyout rumors; j2 Global active
8/12/2019	CV	Market Commentary: Akamai, Workiva on tap; Insight Enterprises eyed; Snap active; Alteryx notes improve
3/20/2019	CV	Market Commentary: Chegg on tap; GOL Linhas accelerates timing; Euronet dominates; Nio notes open up
3/20/2019	CV	Market Commentary: Morning Commentary: Convertibles secondary space quiet; Euronet continues to dominate
3/8/2019	CV	Market Commentary: Pluralsight convertible notes in focus; Aceto jumps; AMAG contracts; NIO down again
11/1/2018	CV	Market Commentary: Wayfair convertibles eyed; Booking Holdings active; AMAG drops; Chesapeake in focus
9/27/2018	BKCV	S&P lifts, then withdraws AMAG Pharma rating
6/18/2018	BKCVHY	S&P puts AMAG on positive watch
6/15/2018	BKCVDDEMIGPV	Market Commentary: PHI joins calendar, existing notes gain; MGM dominates; Ardent trades up; AMAG jumps
6/15/2018	CV	Market Commentary: TPG Specialty, Canopy convertibles price; Intelsat up 12 points on week; AMAG in focus
6/15/2018	CV	Market Commentary: Morning Commentary: TPG Specialty, Canopy price; Intelsat up 12 points dollar neutral
4/12/2018	CV	Market Commentary: Transocean convertibles in focus; primary quiet; biotech sector firm; Caesars active
2/20/2018	CV	Market Commentary: Q2 Holdings on tap; NXP Semiconductors active on buyout offer increase; AMAG tops par
2/15/2018	BKCVDDEMIGPV	Market Commentary: Primary stays quiet, overall market firms; Bombardier up on Q4; funds plunge $6.3 billion
2/15/2018	CV	Market Commentary: AMAG convertibles in focus; Red Hat reaches new heights; Oil States drops below par
2/15/2018	CV	Market Commentary: Morning Commentary: Inpixon prices convertible preferred offering; AMAG in focus
1/30/2018	BKCVHY	S&P lowers AMAG, notes
11/3/2017	CV	Market Commentary: Convertibles mixed; Intel pulls back but up for week; AMAG finds footing after tumble
11/3/2017	CV	Market Commentary: Morning Commentary: Convertibles mixed; AMAG finds footing after tumble following lowered guidance
8/18/2017	CV	Market Commentary: Jazz prices at discount, fades post-pricing; AMAG convertibles hold steady; DyCom sees action
8/18/2017	CV	Market Commentary: Morning Commentary: Jazz prices at discount, fades post-pricing; AMAG convertibles hold steady
5/12/2017	BKCVHY	Moody’s raises AMAG notes to Ba3
5/8/2017	BKCVHY	S&P affirms AMAG, lifts notes to BB-
5/5/2017	CV	Market Commentary: AMAG deal comes upsized, cheap; HubSpot ‘aggressively priced’; Herbalife edges higher
5/5/2017	CV	Market Commentary: Morning Commentary: AMAG Pharmaceuticals deal comes upsized, cheap; HubSpot prices rich
5/5/2017	CV	New Issue: AMAG sells upsized $300 million five-year convertibles yield 3.25%, up 37.5%
5/4/2017	CV	Market Commentary: Spirit Realty convertibles tumble on earnings miss; Lumentum trades higher on 3D hopes
5/3/2017	CV	Market Commentary: AMAG, HubSpot add deals to calendar; Tesla drops ahead of earnings; Akamai trades off
5/3/2017	CV	AMAG offers $250 million five-year convertible notes at 2.75%-3.25% yield, up 37.5%-42.5%
2/21/2017	BKCVHY	Moody’s revises AMAG view to stable
1/9/2017	CV	Market Commentary: Ariad Pharmaceuticals jumps on Takeda takeover news; AMAG paper suffers; Nabors deal on tap
11/19/2015	CV	Market Commentary: Chesapeake Energy gaps down; AMAG continues trajectory lower; Vodafone prices Ł600 million
11/19/2015	CV	Market Commentary: Morning Commentary: AMAG continues trajectory lower; Vodafone launches Ł500 million convertible
11/18/2015	BKBWCVHY	AMAG Pharmaceuticals ends third quarter with $1.1 billion total debt
11/4/2015	CV	Market Commentary: Tesla convertibles flat after earnings miss; Anthem adds on swap; FireEye contracts
11/4/2015	CV	Market Commentary: Morning Commentary: Convertibles primary remains quiet; Tesla Motors adds after earnings miss
11/3/2015	CV	Market Commentary: AMAG Pharmaceuticals tumbles outright on earnings miss; Priceline edges up; Ctrip in line
9/25/2015	CV	Market Commentary: Biotechnology names lower outright; AMAG Pharmaceuticals moves in line in active trade
9/25/2015	CV	Market Commentary: Morning Commentary: AMAG Pharmaceuticals moves in line in continued active trade
8/13/2015	BKCVDDEMIGPV	Market Commentary: No pricings; Oneok hits road; new Post, AMAG issues firm smartly; funds lose $1.21 billion
8/12/2015	BKCVDDEMIGPV	Market Commentary: Post two-part megadeal, upsized AMAG Pharmaceuticals price, AMAG gains; broad market lower
8/5/2015	BKCVHY	Moody’s rates AMAG loan Ba2, notes B3
8/4/2015	BKCV	S&P lifts AMAG; rates loan BB, notes B+
10/31/2014	BKCV	S&P assigns AMAG loan B+
10/29/2014	BKCV	Moody’s assigns AMAG CFR B2, loan Ba3
4/10/2014	CV	Market Commentary: Convertibles mostly steady, some vol. names up as equities slide; WellPoint flat; AMAG slips
2/21/2014	CV	Market Commentary: Brookdale adds dollar neutral after acquisition news; Iconix mostly in line; AMAG gains
2/21/2014	CV	Market Commentary: Midday Commentary: AMAG Pharmaceuticals trades up slightly; Brookdale responds to acquisition news
2/14/2014	CV	AMAG greenshoe lifts 2.5% five-year convertibles to $200 million
2/13/2014	CV	Market Commentary: Imperial gains in modest trade; planned Akamai sees par bid; Medicines expands on hedge
2/12/2014	CV	Market Commentary: Midday Commentary: Upsized AMAG, upsized Canadian Solar both add; Imperial Holdings on tap
2/12/2014	CV	New Issue: AMAG Pharmaceuticals sells upsized $175 million five-year convertibles at 2.5%, up 35%
2/12/2014	CV	Market Commentary: Upsized Canadian Solar jumps on debut; upsized AMAG adds; Imperial Holdings, Akamai on tap
2/11/2014	CV	Market Commentary: Midday Commentary: Planned AMAG looks cheap; Canadian Solar launches $100 million deal
2/11/2014	CV	Market Commentary: Planned AMAG looks cheap; Canadian Solar launches; WebMD slips outright, adds on hedge
2/10/2014	CV	AMAG Pharmaceuticals plans $150 million five-year convertibles to yield 2.25%-2.75%, up 30%-35%
2/10/2014	CV	Market Commentary: AMAG Pharmaceuticals offers $150 million deal; Xilinx 3.125% notes steady; Medicines down
1/19/2010	CVHY	AMAG Pharmaceuticals files automatic shelf to sell debt, stock

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.